Literature DB >> 23637420

Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.

Zeguang Wu1, Christian Sinzger, Giada Frascaroli, Johanna Reichel, Carina Bayer, Li Wang, Reinhold Schirmbeck, Thomas Mertens.   

Abstract

Recent studies indicate that expansion of NKG2C-positive natural killer (NK) cells is associated with human cytomegalovirus (HCMV); however, their activity in response to HCMV-infected cells remains unclear. We show that NKG2C(hi) CD57(hi) NK cells gated on CD3(neg) CD56(dim) cells can be phenotypically identified as HCMV-induced NK cells that can be activated by HCMV-infected cells. Using HCMV-infected autologous macrophages as targets, we were able to show that these NKG2C(hi) CD57(hi) NK cells are highly responsive to HCMV-infected macrophages only in the presence of HCMV-specific antibodies, whereas they are functionally poor effectors of natural cytotoxicity. We further demonstrate that NKG2C(hi) CD57(hi) NK cells are intrinsically responsive to signaling through CD16 cross-linking. Our findings show that the activity of pathogen-induced innate immune cells can be enhanced by adaptive humoral immunity. Understanding the activity of NKG2C(hi) CD57(hi) NK cells against HCMV-infected cells will be of relevance for the further development of adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637420      PMCID: PMC3700275          DOI: 10.1128/JVI.01096-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

Authors:  T L Chapman; A P Heikeman; P J Bjorkman
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

Review 2.  Natural killer cell receptor signaling.

Authors:  Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2003-06       Impact factor: 7.486

3.  Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.

Authors:  J A D'Orazio; G W Burke; J Stein-Streilein
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

4.  Natural killer cell responses in renal transplant patients with cytomegalovirus infection.

Authors:  H Venema; A P van den Berg; C van Zanten; W J van Son; M van der Giessen; T H The
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

5.  Severe herpesvirus infections in an adolescent without natural killer cells.

Authors:  C A Biron; K S Byron; J L Sullivan
Journal:  N Engl J Med       Date:  1989-06-29       Impact factor: 91.245

6.  Specific and nonspecific NK cell activation during virus infection.

Authors:  A O Dokun; S Kim; H R Smith; H S Kang; D T Chu; W M Yokoyama
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

7.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Authors:  P Tomasec; V M Braud; C Rickards; M B Powell; B P McSharry; S Gadola; V Cerundolo; L K Borysiewicz; A J McMichael; G W Wilkinson
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

8.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

9.  In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.

Authors:  B Hertenstein; W Hampl; D Bunjes; M Wiesneth; C Duncker; U Koszinowski; H Heimpel; R Arnold; T Mertens
Journal:  Bone Marrow Transplant       Date:  1995-03       Impact factor: 5.483

10.  KIR2DL4 (CD158d) genotype influences expression and function in NK cells.

Authors:  Jodie P Goodridge; Campbell S Witt; Frank T Christiansen; Hilary S Warren
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  58 in total

1.  Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.

Authors:  Letizia Muccio; Alice Bertaina; Michela Falco; Daniela Pende; Raffaella Meazza; Miguel Lopez-Botet; Lorenzo Moretta; Franco Locatelli; Alessandro Moretta; Mariella Della Chiesa
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

2.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

Review 3.  MCMV avoidance of recognition and control by NK cells.

Authors:  Ilija Brizić; Tihana Lenac Roviš; Astrid Krmpotić; Stipan Jonjić
Journal:  Semin Immunopathol       Date:  2014-08-21       Impact factor: 9.623

4.  Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals.

Authors:  Jaewon Lee; Tianxiang Zhang; Ilwoong Hwang; Ahrom Kim; Larissa Nitschke; MinJae Kim; Jeannine M Scott; Yosuke Kamimura; Lewis L Lanier; Sungjin Kim
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

5.  Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Authors:  Zeguang Wu; Giada Frascaroli; Carina Bayer; Tatjana Schmal; Thomas Mertens
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

6.  Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.

Authors:  Zeguang Wu; Ruifang Qin; Li Wang; Matteo Bosso; Myriam Scherer; Thomas Stamminger; Dominik Hotter; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 7.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

8.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

9.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

Review 10.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.